Retraction: Hypoxia-Inducible MiR-210 Is an Independent Prognostic Factor and Contributes to Metastasis in Colorectal Cancer (PLoS ONE (2015) 9:3 (e90952) DOI: 10.1371/journal.pone.0090952);Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Qu, Ailin ^a   Du, Lutao ^a   Yang, Yongmei ^a   Liu, Hui ^a   Li, Juan ^a   Wang, Lili ^a   Liu, Yimin ^a   Dong, Zhaogang ^a   Zhang, Xin ^a   Jiang, Xiumei ^a   Wang, Haiyan ^a   Li, Zewu ^a   Zheng, Guixi ^a   Wang, Chuanxin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; MICRORNA 210; UNCLASSIFIED DRUG; VACUOLE MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; MICRORNA; MIRN210 MICRORNA, HUMAN; VMP1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR VOLUME; UPREGULATION; CELL LINE; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; IN VITRO STUDY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; IN VITRO TECHNIQUES; LYMPHATIC METASTASIS; MEMBRANE PROTEINS; MICRORNAS; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 84898408557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0244280     Document Type: Erratum

References (41)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA: a cancer journal for clinicians 62: 10-29.
2. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA: a cancer journal for clinicians 55: 74-108. (Pubitemid 40372904)
3. Lorusso G, Ruegg C (2008) The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 130: 1091-1103.
4. Brown JM, Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer research 58: 1408-1416. (Pubitemid 28193601)
5. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, et al. (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer research 56: 4509-4515. (Pubitemid 26330463)
6. Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nature reviews 2: 38-47.
7. Lan KL, Lan KH, Sheu ML, Chen MY, Shih YS, et al. (2011) Honokiol inhibits hypoxia-inducible factor-1 pathway. International journal of radiation biology 87: 579-590.
8. Williams KJ, Telfer BA, Xenaki D, Sheridan MR, Desbaillets I, et al. (2005) Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1. Radiother Oncol 75: 89-98. (Pubitemid 40616800)
9. Tsai YP, Wu KJ (2012) Hypoxia-regulated target genes implicated in tumor metastasis. Journal of biomedical science 19: 102.
10. Voss MJ, Niggemann B, Zanker KS, Entschladen F (2010) Tumour reactions to hypoxia. Current molecular medicine 10: 381-386.
11. Kobayashi M, Nakagawa K (2010) Metastasis and hypoxia-inducible factor. Gan to kagaku ryoho Cancer & chemotherapy 37: 2047-2051.
12. Cao D, Hou M, Guan YS, Jiang M, Yang Y, et al. (2009) Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC cancer 9: 432.
13. Fan LF, Dong WG, Jiang CQ, Qian Q, Yu QF (2008) Role of Hypoxia-inducible factor-1 alpha and Survivin in colorectal carcinoma progression. International journal of colorectal disease 23: 1057-1064.
14. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
15. Hanahan D,Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
16. Chen HY, Lin YM, Chung HC, Lang YD, Lin CJ, et al. (2012) miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer research 72: 3631-3641.
17. Bao B, Ali S, Ahmad A, Azmi AS, Li Y, et al. (2012) Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. PloS one 7: e50165.
18. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, et al. (2007) A microRNA signature of hypoxia. Molecular and cellular biology 27: 1859-1867.
19. Crosby ME, Devlin CM, Glazer PM, Calin GA, Ivan M (2009) Emerging roles of microRNAs in the molecular responses to hypoxia. Current pharmaceutical design 15: 3861-3866.
20. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, et al. (2009) Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Molecular cell 35: 856-867.
21. Ying Q, Liang L, Guo W, Zha R, Tian Q, et al. (2011) Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology (Baltimore, Md 54: 2064-2075.
22. Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, et al. (2013) MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumour Biol 34: 481-491.
23. Rothe F, Ignatiadis M, Chaboteaux C, Haibe-Kains B, Kheddoumi N, et al. (2011) Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer. PloS one 6: e20980.
24. Hong L, Yang J, Han Y, Lu Q, Cao J, et al. (2012) High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis. Gene 507: 135-138.
25. Vosa U, Vooder T, Kolde R, Vilo J, Metspalu A, et al. (2013) Meta-analysis of microRNA expression in lung cancer. International journal of cancer Journal international du cancer 132: 2884-2893.
26. Wotschofsky Z, Busch J, Jung M, Kempkensteffen C, Weikert S, et al. (2013) Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy. Clinica chimica acta; international journal of clinical chemistry 416: 5-10.
27. Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, et al. (2008) miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer biology & therapy 7: 255-264. (Pubitemid 351590433)
28. Tsuchiya S (2012) The role of microRNA-210 in esophageal squamous cell carcinoma. Yakugaku Zasshi 132: 1069-1073.
29. Schee K, Lorenz S, Worren MM, Gunther CC, Holden M, et al. (2013) Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer. PloS one 8: e66165.
30. Noman MZ, Buart S, Romero P, Ketari S, Janji B, et al. (2012) Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells. Cancer research 72: 4629-4641.
31. Cai H, Lin L, Cai H, Tang M, Wang Z (2013) Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma. Medical oncology (Northwood, London, England) 30: 499.
32. Tsuchiya S, Fujiwara T, Sato F, Shimada Y, Tanaka E, et al. (2011) MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). The Journal of biological chemistry 286: 420-428.
33. Greither T, Wurl P, Grochola L, Bond G, Bache M, et al. (2012) Expression of microRNA 210 associates with poor survival and age of tumor onset of soft-tissue sarcoma patients. International journal of cancer Journal international du cancer 130: 1230-1235.
34. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, et al. (2008) hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14: 1340-1348. (Pubitemid 351413913)
35. Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, et al. (2010) hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 116: 2148-2158.
36. Bianchi N, Zuccato C, Lampronti I, Borgatti M, Gambari R (2009) Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression. BMB reports 42: 493-499.
37. Qin L, Chen Y, Niu Y, Chen W, Wang Q, et al. (2010) A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway. BMC genomics 11: 320.
38. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, et al. (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. The Journal of biological chemistry 283: 15878-15883.
39. Vaccaro MI, Grasso D, Ropolo A, Iovanna JL, Cerquetti MC (2003) VMP1 expression correlates with acinar cell cytoplasmic vacuolization in arginine-induced acute pancreatitis. Pancreatology: official journal of the International Association of Pancreatology 3: 69-74.
40. Sauermann M, Sahin O, Sultmann H, Hahne F, Blaszkiewicz S, et al. (2008) Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells. Oncogene 27: 1320-1326. (Pubitemid 351294693)
41. Farazi TA, Spitzer JI, Morozov P, Tuschl T (2011) miRNAs in human cancer. The Journal of pathology 223: 102-115.